Goleij P, Heidari M, Tabari M, Hadipour M, Rezaee A, Javan A
Funct Integr Genomics. 2025; 25(1):53.
PMID: 40048009
DOI: 10.1007/s10142-025-01563-8.
Liapodimitri A, Tetens A, Craig-Schwartz J, Lunsford K, Skalitzky K, Koldobskiy M
Cancers (Basel). 2025; 16(24.
PMID: 39766049
PMC: 11674401.
DOI: 10.3390/cancers16244149.
Chen Z, Jiang H, Qin Q, Li Q, Hong L
Front Genet. 2024; 15:1403907.
PMID: 38911294
PMC: 11190699.
DOI: 10.3389/fgene.2024.1403907.
Sato H, Watanabe K, Kobayashi Y, Tomihari M, Uemura A, Tagawa M
Animals (Basel). 2023; 13(18).
PMID: 37760387
PMC: 10525518.
DOI: 10.3390/ani13182987.
Della Via F, Alvarez M, Basting R, Olalla Saad S
Pharmaceuticals (Basel). 2023; 16(7).
PMID: 37513933
PMC: 10385775.
DOI: 10.3390/ph16071021.
Synthesis and In Vitro Biological Evaluation of -Carborane-Based Di--butylphenol Analogs.
Braun S, Jelaca S, Laube M, George S, Hofmann B, Lonnecke P
Molecules. 2023; 28(11).
PMID: 37299023
PMC: 10254233.
DOI: 10.3390/molecules28114547.
Genome-wide differential DNA methylation analysis of MDA-MB-231 breast cancer cells treated with curcumin derivatives, ST08 and ST09.
Nirgude S, Desai S, Choudhary B
BMC Genomics. 2022; 23(1):807.
PMID: 36474139
PMC: 9727864.
DOI: 10.1186/s12864-022-09041-2.
Epigenetic Regulation of Cellular Senescence.
Crouch J, Shvedova M, Thanapaul R, Botchkarev V, Roh D
Cells. 2022; 11(4).
PMID: 35203320
PMC: 8870565.
DOI: 10.3390/cells11040672.
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia.
Pappalardi M, Keenan K, Cockerill M, Kellner W, Stowell A, Sherk C
Nat Cancer. 2021; 2(10):1002-1017.
PMID: 34790902
PMC: 8594913.
Epigenetic Alterations in Pancreatic Cancer Metastasis.
Wang S, Xu J, Ji K, Hwang C
Biomolecules. 2021; 11(8).
PMID: 34439749
PMC: 8394313.
DOI: 10.3390/biom11081082.
Epigenomics in Hurthle Cell Neoplasms: Filling in the Gaps Towards Clinical Application.
Canberk S, Lima A, Pinto M, Soares P, Maximo V
Front Endocrinol (Lausanne). 2021; 12:674666.
PMID: 34108939
PMC: 8181423.
DOI: 10.3389/fendo.2021.674666.
Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications.
Duan J, Nie R, Xiang Z, Chen J, Deng M, Liang H
J Hepatocell Carcinoma. 2021; 8:493-505.
PMID: 34095004
PMC: 8170593.
DOI: 10.2147/JHC.S309451.
DNA Methylation and HPV-Associated Head and Neck Cancer.
Nakagawa T, Kurokawa T, Mima M, Imamoto S, Mizokami H, Kondo S
Microorganisms. 2021; 9(4).
PMID: 33920277
PMC: 8069883.
DOI: 10.3390/microorganisms9040801.
Nuclear receptor corepressor (NCoR) is a positive prognosticator for cervical cancer.
Beilner D, Kuhn C, Kost B, Vilsmaier T, Vattai A, Kaltofen T
Arch Gynecol Obstet. 2021; 304(5):1307-1314.
PMID: 33861372
PMC: 8490237.
DOI: 10.1007/s00404-021-06053-3.
Quantification of Global DNA Methylation in Canine Mammary Gland Tumors Immunostaining of 5-Methylcytosine: Histopathological and Clinical Correlations.
Biondi L, Tedardi M, Gentile L, Chamas P, Dagli M
Front Vet Sci. 2021; 8:628241.
PMID: 33718471
PMC: 7947677.
DOI: 10.3389/fvets.2021.628241.
Profiling Chromatin Accessibility at Single-cell Resolution.
Sinha S, Satpathy A, Zhou W, Ji H, Stratton J, Jaffer A
Genomics Proteomics Bioinformatics. 2021; 19(2):172-190.
PMID: 33581341
PMC: 8602754.
DOI: 10.1016/j.gpb.2020.06.010.
Bivalent Genes Targeting of Glioma Heterogeneity and Plasticity.
Markouli M, Strepkos D, Papavassiliou K, Papavassiliou A, Piperi C
Int J Mol Sci. 2021; 22(2).
PMID: 33430434
PMC: 7826605.
DOI: 10.3390/ijms22020540.
The Versatility of Sirtuin-1 in Endocrinology and Immunology.
Rasha F, McDaniel Mims B, Castro-Piedras I, Barnes B, Grisham M, Layeequr Rahman R
Front Cell Dev Biol. 2020; 8:589016.
PMID: 33330467
PMC: 7717970.
DOI: 10.3389/fcell.2020.589016.
VRK1 Phosphorylates Tip60/KAT5 and Is Required for H4K16 Acetylation in Response to DNA Damage.
Garcia-Gonzalez R, Morejon-Garcia P, Campillo-Marcos I, Salzano M, Lazo P
Cancers (Basel). 2020; 12(10).
PMID: 33076429
PMC: 7650776.
DOI: 10.3390/cancers12102986.
Epigenetic inactivation of IRX4 is responsible for acceleration of cell growth in human pancreatic cancer.
Chakma K, Gu Z, Abudurexiti Y, Hata T, Motoi F, Unno M
Cancer Sci. 2020; 111(12):4594-4604.
PMID: 32894817
PMC: 7734003.
DOI: 10.1111/cas.14644.